GlobeNewswire 2022-03-08 Inozyme Pharma Strengthens Management Team with Two Executive Appointments
GlobeNewswire 2022-03-07 EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer
GlobeNewswire 2022-03-03 Lantheus to Host Inaugural Investor Day
GlobeNewswire 2022-03-01 Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member
GlobeNewswire 2022-02-24 Palette Life Sciences Enters Into an Agreement with Lantheus to Support the Promotion of PYLARIFY® (...
GlobeNewswire 2022-02-24 Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-02-23 Nicox Announces VYZULTA Now Commercialized in 7 Territories and Approved in Further 9 Countries
GlobeNewswire 2022-02-10 Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting
GlobeNewswire 2022-02-10 Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on ...
GlobeNewswire 2022-01-27 Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabl...
GlobeNewswire 2021-12-01 Lantheus Appoints Vivian Yao as Chief Human Resources Officer
GlobeNewswire 2021-11-29 Lantheus Announces PYLARIFY AI™ is Now Available
GlobeNewswire 2021-11-29 Journey Medical Corporation Introduces Expanded Board of Directors
GlobeNewswire 2021-11-22 Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) I...
GlobeNewswire 2021-11-17 Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its PSMA-Targete...
GlobeNewswire 2021-11-17 Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europe
GlobeNewswire 2021-11-16 Lantheus Holdings to Present at the 4th Annual Evercore ISI HealthCONx Conference
GlobeNewswire 2021-11-16 Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy...
GlobeNewswire 2021-11-10 Eyenovia Reports Third Quarter 2021 Financial Results
GlobeNewswire 2021-11-04 Eyenovia Announces First Patient Enrolled in Phase 3 VISION-2 Trial of MicroLine for Presbyopia
GlobeNewswire 2021-11-04 Lantheus Holdings, Inc. Reports Third Quarter 2021 Financial Results
GlobeNewswire 2021-10-28 Lantheus Holdings to Present at Upcoming Investor Conferences
GlobeNewswire 2021-10-21 Lantheus Holdings to Host Third Quarter 2021 Earnings Conference Call and Webcast on November 4, 202...
GlobeNewswire 2021-10-13 Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Spec...
GlobeNewswire 2021-10-04 Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scien...